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Abstract
Objective: To study whether maternal cigarette smoking during pregnancy is associated with alterations in the growth of
fetal lungs, kidneys, liver, brain, and placenta.
Design: A case-control study, with operators performing the image analysis blinded.
Setting: Study performed on a research-dedicated magnetic resonance imaging (MRI) scanner (1.5 T) with participants
recruited from a large teaching hospital in the United Kingdom.
Participants: A total of 26 pregnant women (13 current smokers, 13 non smokers) were recruited; 18 women (10 current
smokers, 8 nonsmokers) returned for the second scan later in their pregnancy.
Methods: Each fetus was scanned with MRI at 22–27 weeks and 33–38 weeks gestational age (GA).
Main outcome measures: Images obtained with MRI were used to measure volumes of the fetal brain, kidneys, lungs, liver
and overall fetal size, as well as placental volumes.
Results: Exposed fetuses showed lower brain volumes, kidney volumes, and total fetal volumes, with this effect being
greater at visit 2 than at visit 1 for brain and kidney volumes, and greater at visit 1 than at visit 2 for total fetal volume.
Exposed fetuses also demonstrated lower lung volume and placental volume, and this effect was similar at both visits. No
difference was found between the exposed and nonexposed fetuses with regards to liver volume.
Conclusion: Magnetic resonance imaging has been used to show that maternal smoking is associated with reduced growth
of fetal brain, lung and kidney; this effect persists even when the volumes are corrected for maternal education, gestational
age, and fetal sex. As expected, the fetuses exposed to maternal smoking are smaller in size. Similarly, placental volumes are
smaller in smoking versus nonsmoking pregnant women.
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Introduction
It is well recognised that adverse environmental conditions can
affect fetal development. Although some of these effects may be
adaptive in the short term, many can have long-term consequenc-
es for the health of the individual in subsequent childhood and
even adulthood [1]. Cigarette smoke contains a multitude of
different compounds that may be harmful to the developing fetus;
although 20% of pregnant smokers quit smoking before the initial
prenatal visit, approximately 15–20% of pregnant women smoke
tobacco during pregnancy despite a strong public-health campaign
over the last few decades [2].
Prenatal exposure to maternal cigarette smoking (PEMCS) is
associated with a wide range of obstetric complications including
increased risk of perinatal mortality, miscarriage, gestational
bleeding, placental abruption, placenta praevia, as well as neonatal
and early-childhood disorders, such as sudden infant death
syndrome (SIDS) and respiratory diseases [3–5]. In particular,
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PEMCS is known to be the most common cause of intrauterine
growth restriction (IUGR) [5]. Despite being born smaller at birth,
individuals exposed prenatally to maternal smoking are at higher
risk for obesity and obesity-associated disorders, such as cardio-
vascular and diabetes outcomes, beginning in childhood or
adolescence [6,7]. There is also evidence suggesting that PEMCS
is associated with a number of adverse outcomes related to the
offspring’s behaviour [8] and brain development [9–11].
In this study, we recruited pregnant women who either smoked
(cases) or did not smoke (controls) cigarettes and investigated fetal
growth using magnetic resonance imaging (MRI) considering the
whole fetus, the placenta, and a number of major organs (brain,
kidneys, lungs and liver). Tobacco smoking is frequently associated
with epiphenomena, such as risky behavior, co-abuse of other
substances, poor prenatal care, and low socioeconomic status,
which will also exert adverse effects on the developing fetus.
Therefore, we attempted to match the cases and controls for
socioeconomic status, age, body mass index (BMI), and parity.
Materials and Methods
This research was conducted at the University of Nottingham
with the approval of the Nottingham Research Ethics Committee,
in accordance with principles of Good Clinical Practice. All
volunteers gave informed written consent to participate in the
study.
Research Participants
Data were collected from 26 healthy pregnant women recruited
from the Queen’s Medical Centre, Nottingham: 13 current
smokers and 13 non-smokers. Only 10 current smokers and
8 non-smokers returned for the second visit and so only their data
were analyzed. Women were eligible to participate if they had a
viable, singleton pregnancy and were aged $18 years. At
recruitment, smokers and non-smokers were matched for age
(63 years: range: 18–36), parity, BMI, and education level
(grouped by a. less than 5 General Certificates of Secondary
Education (GCSEs: school leaving qualification taken by 16 year
olds in the UK), b. more than 5 GCSEs, c. A-levels (standard
method of assessing admission to undergraduate studies in the UK
and is generally taken at 18 years old), d. university degree). All of
these data were collected through questionnaires administered by
their obstetricians.
At each clinic visit, participants were asked to record their
smoking status, and if they were smokers, the quantity, frequency
and tobacco brand used. Gestational age was established using the
crown-rump length based on ultrasound, carried out at the time of
the routine dating scan. Two MRI scans were performed at
gestational ages of 24 (62) weeks and 35 (62) weeks.
MRI Acquisition
All scans were conducted using a 1.5 tesla Philips Achieva MRI
system using either a 5-element SENSE cardiac or 4-element
SENSE torso receive coil, depending on the woman’s size. Women
lay on their right side in the decubitus position to avoid
compression of the vena cava, and scans were performed with a
specific absorption rate of ,2.0 W kg21.
Three sequences were acquired to give a range of contrasts and
resolutions for different organs: (1) HASTEbody: Half Fourier
Single Shot Turbo Spin-Echo (HASTE); 123 slices in 147 seconds,
TE = 120 ms, 0.7860.7866.00 mm3 voxels, (2) HASTEbrain: to
provide higher spatial resolution particularly over the brain (34
slices in 36 seconds, TE = 120 ms, 0.5960.5964.50 mm3 voxels)
and (3) bFFE: Balanced Fast Field Echo (130 slices in 167 seconds,
TR = 5.8 ms, TE = 2.3 ms, flip angle = 70u, 0.7860.7866.00 mm3
voxels). All sequences were acquired in three orthogonal blocks of
images, without breath holding. This over-acquisition of the data
allowed the effects of motion and artifacts to be excluded or
averaged out.
Figure 1. MR Images through the fetal brain in three orthogonal planes (HASTEbrain sequences), 24 weeks (V1) and 35 weeks (V2).
doi:10.1371/journal.pone.0067223.g001
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Image Analysis
Volumes (cm3) were estimated by drawing a region of interest
(ROI) around the organ of interest in a series of images of
contiguous slices and then summing the areas of the ROI in each
slice and multiplying by the slice thickness. Two approaches were
used to measure areas, with a different, blinded operator
undertaking each. The first was manual segmentation of every
slice using semi-automatic edge detection (Analyze 9.0, Mayo
Clinic, Rochester, MN, USA), which was used for smooth, high
contrast objects (fetal kidneys and lungs, total fetus and placenta
on bFFE, and lungs on HASTEbrain). The second was the
Cavalieri stereological method, which was applied in combination
with point counting (EasyMeasure software, University of Liver-
pool, UK) [12–15]. A 20620 voxel grid was superimposed on the
image, and the fraction of the grid points lying within the ROI
gave the fraction of the whole area of the image representing the
ROI. This segmentation technique was used to measure fetal brain
and liver on the HASTEbrain data. If, for any participants, the
HASTEbrain images were seriously affected by motion or signal
non-uniformity artifacts, then HASTEbody scans were used
instead. Volumes were measured on all relevant slices from at
least two of the orthogonal blocks of images acquired from each
sequence and averaged. These two estimates differed by approx-
imately 0–10% from the mean. Finally, the volume of each organ
as a percentage of the total fetal volume was calculated (% volume
for each organ).
Fetal length (cm) was calculated from the sum of the length of
the fetal spine (measured in two curved sections), thigh, lower leg
and skull height (crown to base of the brain stem) on bFFE and
HASTE images using Analyze 9.0. In order to measure the length
of the spine, the multi-slice images were resampled obliquely. Fetal
Table 1. Demographics and the delivery details for all mothers.
Characteristic Normal (n = 8) Smoker (n = 10)
Mean SD Range Mean SD Range
Maternal age (years) 29.5 4.9 20–33 24.7 4.2 18–29
Weight (kg) 71.1 11.2 59–92 65.9 13.8 55–88
Height (cm) 167.5 6.5 162–176 166.4 4.1 160–175
BMI 24.5 3.7 20–30 23.4 5.5 18–33
Parity 0.5 0.8 0–2 1.2 1.2 0–3
Cigarette smoked per day N/A N/A N/A 9 4 4–15
Gestational age at delivery
(weeks+days)*
39.9 1.4 37.3–41.9 39.8 1.4 37.7–41.6
Birth weight (g)* 3547 597 2880–4220 3036 582 2170–4140
Education 1 with 0 GCSEs, 1 with ,5 GCSEs, 4 with .5 GCSEs, 1 with A-
Levels and 1 with a degree
2 with 0 GCSEs, 5 with ,5 GCSEs and 3 with .5 GCSEs
Delivery 2 Emergency Caesarean, 1 elective Caesarean deliveries 2 Ventouse deliveries
*Note that the estimated means and standard deviations for gestation at delivery and birth weight were corrected for fetal sex, maternal education (education was re-
coded as an ordinal variable: 0 = 0 GCSEs; 1 =,5 GCSEs; 2 =.5 GCSEs/A-levels/degree), and maternal age as derived from the ANCOVA (IBM SPSS Statistics Version 20,
NY, USA).
doi:10.1371/journal.pone.0067223.t001
Table 2. The effect of exposure on the volume of fetal organs
was assessed using a mixed model ANCOVA.
Volumes p-values
Exposure (Main Effect) Exposure6Visit
Brain 0.020 0.079
Lung 0.018 0.166
Kidney ,0.001 0.001
Liver 0.106 0.152
Placenta 0.022 0.685
Total Fetal 0.003 0.009
Percentage Brain 0.051 0.473
Percentage Lung 0.564 0.735
Percentage Kidney 0.04 0.595
Percentage Liver 0.867 0.919
Each independent analysis included one within-subject variable of visit and one
between-subject variable of exposure to maternal cigarette smoking, with four
covariates.
doi:10.1371/journal.pone.0067223.t002
Table 3. The mean and standard error for fetal organ
volumes, placenta volume and total fetal volume at Visit 1.
Visit 1
Volumes Non Exposed Exposed p-values
Mean (cm3) SEM (cm3) Mean (cm3) SEM (cm3)
Brain 76.737 3.236 69.018 2.824 0.129
Lung 44.719 2.362 35.470 2.062 0.020
Kidney 18.925 1.554 13.255 1.357 0.028
Liver 62.285 5.104 53.075 3.650 0.205
Placenta 469.719 46.126 280.283 40.257 0.016
Total
Fetal
719.206 21.657 593.963 18.901 0.002
The mean and standard error were corrected for fetal sex, maternal education
(education was re-coded as an ordinal variable: 0 = 0 GCSEs; 1 =,5 GCSEs;
2 =.5 GCSEs/A-levels/degree), gestational age at Visit 1 and the difference in
gestational age between Visits 1 and 2.
doi:10.1371/journal.pone.0067223.t003
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Volume Index (FVI) was calculated as the ratio of Fetal Volume to
Fetal Length.
Statistical Methods
Independent sample t-tests were used to examine group
differences in maternal age, maternal BMI and maternal parity.
A chi-square test was used to examine group differences in
maternal education.
A univariate analysis of co-variance (ANCOVA) was completed
for birth weight and gestational age at birth (weeks). Each
independent analysis included one between-subject variable of
exposure to maternal cigarette smoking. Three covariates were
included in these analyses: fetal sex, maternal education (education
was re-coded as an ordinal variable: 0 = 0 GCSEs; 1 =,5 GCSEs;
2 =.5 GCSEs/A-levels/degree) and maternal age. Post-hoc
comparison analyses were completed with a Bonferroni correction
for multiple comparisons.
A mixed-model ANCOVA was completed for the following fetal
variables of interest: brain volume, kidney volume, lung volume,
liver volume, total fetal volume, placental volume, FVI, percentage
brain volume, percentage kidney volume, percentage lung volume
and percentage liver volume. Each independent analysis included
one within-subject variable of visit (24 weeks, 35 weeks) and one
between-subject variable of exposure to maternal cigarette
smoking. Four covariates were included in all analyses: fetal sex,
maternal education (education was re-coded as an ordinal
variable: 0 = 0 GCSEs; 1 =,5 GCSEs; 2 =.5 GCSEs/A-
levels/degree), gestational age at Visit 1 and the difference in
gestational age between Visits 1 and 2. Post-hoc comparison
analyses were completed with a Bonferroni correction for multiple
comparisons.
Results
Typical images of the fetal brain are shown in Figure 1.
Table 1 shows the demographics and the delivery details for all
mothers. Smoking mothers smoked 964 cigarettes per day.
Although participants were matched at recruitment, due to drop
out, smoking mothers who completed the study were significantly
younger than non-smoking mothers [by 4.8 years, p = 0.041],
although they did not differ in parity, height, or adiposity.
Similarly, smoking mothers were less educated than non-smoking
mothers, but this difference was not significant (p = 0.056). At
delivery, babies of smoking mothers (exposed) did not differ from
babies of non-smoking mothers (non-exposed) with respect to their
birth weight (p = 0.124). The exposed babies also did not differ in
their gestational age at delivery (p = 0.868). There were no cases of
pre-eclampsia in either group. However, there were two cases of
pregnancy-induced hypertension (one in each group). Pregnancy
induced hypertension is defined as blood pressure .140/
90 mmHg observed on two separate occasions (.4 hours apart)
and in the absence of proteinuria. There were two cases of fetal
growth restriction in the exposed group; fetal growth restriction is
defined as birth weight below the 10th centile corrected for
gestational age at delivery, infant’s sex, and whether a first-born or
not [16].
Table 2 shows the effect of exposure on the volume of fetal
organs, assessed using a mixed model ANCOVA. Tables 3 and
4 show the mean and standard error for fetal organ volumes,
placenta volume and total fetal volume at Visit 1 and 2,
respectively. Exposed fetuses showed lower brain volume
(Figure 2, p = 0.02), with this effect being greater at Visit 2
(Cohen’s d = 1.31) than Visit 1 (Cohen’s d = 0.85; but note that the
exposure 6 visit interaction failed to reach significance [p =
0.079]). Exposed fetuses showed lower kidney volume (Figure 3,
exposure 6 visit interaction: p = 0.001) and total fetal volume
(Figure 4, exposure6visit interaction: p = 0.009) compared with
Table 4. The mean and standard error for fetal organ
volumes, placenta volume and total fetal volume at Visit 2.
Visit 2
Volumes Non Exposed Exposed p-values
Mean (cm3) SEM (cm3) Mean (cm3) SEM (cm3)
Brain 277.506 8.504 246.453 7.422 0.028
Lung 125.300 9.617 94.694 8.393 0.051
Kidney 53.500 3.051 30.451 2.662 ,0.001
Liver 234.143 19.464 189.354 13.920 0.116
Placenta 862.388 74.402 728.033 64.934 0.241
Total Fetal 2871.135 133.065 2202.110 116.132 0.005
The mean and standard error were corrected for fetal sex, maternal education
(education was re-coded as an ordinal variable: 0 = 0 GCSEs; 1 =,5 GCSEs;
2 =.5 GCSEs/A-levels/degree), gestational age at Visit 1 and the difference in
gestational age between Visits 1 and 2.
doi:10.1371/journal.pone.0067223.t004
Figure 2. Brain growth data showing group results at both
visits and individual data.
doi:10.1371/journal.pone.0067223.g002
Figure 3. Kidney growth data showing group results at both
visits and individual data.
doi:10.1371/journal.pone.0067223.g003
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non-exposed fetuses at both Visit 1 (kidney: p = 0.028, Cohen’s
d = 1.31; total fetal volume: p = 0.002, Cohen’s d = 2.07) and Visit
2 (kidney: p,0.001, Cohen’s d = 2.70; total fetal volume:
p = 0.005, Cohen’s d = 1.80). Exposed fetuses also demonstrated
lower lung volume (Figure 5, p = 0.018) and placental volume
(Figure 6, p = 0.022), and this effect was similar at both visits. No
difference was found between the exposed and non-exposed
fetuses with regards to liver volume (p . 0.1). Exposed fetuses also
showed lower percentage kidney volume (p = 0.04) and percentage
brain volume (p = 0.051). No differences were found between the
exposed and non-exposed fetuses with regard to percentage lungs
and liver volume. Finally, exposed fetuses showed a lower FVI
(p = 0.047) compared with non-exposed fetuses.
Discussion
This study has confirmed that PEMCS is associated with a
reduced volume of multiple fetal organs, and that in some cases
this effect can be detected as early as mid-pregnancy (,22 weeks).
Whilst women continue smoking in pregnancy, this work, along
with other studies focusing on the effect of PEMCS, addresses the
recent request from the Department of Health directed towards
the National Institute for Health and Clinical Excellence (NICE)
to provide public health guidance on interventions aimed at
stopping smoking in pregnancy [17]. Many of these interventions
focus on providing information about the risks of PEMCS to the
unborn child.
Nicotine and carbon monoxide have been identified as two
major compounds in cigarette smoke that may have harmful
effects on the developing fetus during pregnancy. They are known
to cross the placenta and can be detected in fetal circulation,
amniotic fluid, and the breast milk of smoking mothers. There is
evidence that the concentration of nicotine in fetal circulation is
15% higher than that found in maternal circulation [18] and that
the concentration of nicotine in the amniotic fluid is 88% higher
than in the maternal plasma [2,18]. Nicotine can affect the fetus in
many ways: (a) vasoconstriction of the uteroplacental vasculature
leading to uteroplacental underperfusion and a reduction in
nutrient and oxygen flow to the fetus [19]; (b) suppression of the
mother’s appetite leading to poor nutrition and energy intake and
resulting in reduced energy supplied to the fetus; and (c) alterations
in the cellular growth and activity of the central and peripheral
nervous system [20]. Carbon monoxide binds with hemoglobin to
form carboxyhemoglobin resulting in depletion in oxygen supplied
to fetal tissue and hypoxia-ischemia. Studies in animal models
demonstrate evidence of histopathological changes in the fetal
lungs, liver, kidneys and placenta in response to cigarette smoke
[21,22].
The reduced brain volume in PEMCS fetuses is consistent with
our previous findings. We have previously demonstrated a smaller
volume of the corpus callosum in female adolescents with PEMCS
[10] and a smaller (by ,14%) total area of the cerebral cortex in
female adolescents with a particular variant of the KCTD8 gene
[9]. It has been suggested that variations in fetal brain growth
associated with prenatal exposure to maternal cigarette smoking
(human studies) or nicotine (experimental studies) might be due to
increased apoptosis of both progenitor cells and post-mitotic
neurons [9,20].
The effect of PEMCS on reducing fetal lung growth was
previously observed in rat fetuses, and is potentially the result of a
reduction in airway size [23]. Recent studies have detailed
microscopic changes in the lungs of fetal rats with prenatal
exposure to nicotine [24,25] or cigarette smoke [22,24] and there
is evidence of increased risk of reduced respiratory function in
infants exposed to maternal smoking during pregnancy [26].
Future studies could use MR techniques to study lung maturation
as well as lung growth in developing fetuses [27].The data also
show that PEMCS particularly affects the growth of fetal kidneys
Figure 4. Fetal growth data showing group results at both
visits and individual data.
doi:10.1371/journal.pone.0067223.g004
Figure 5. Lung growth data showing group results at both
visits and individual data.
doi:10.1371/journal.pone.0067223.g005
Figure 6. Placental growth data showing group results at both
visits and individual data.
doi:10.1371/journal.pone.0067223.g006
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and kidney growth rate; this result persists after correcting for total
fetal volume, indicating that the reduction in fetal kidney volume is
not a result of fetal growth restriction. This result agrees with
previous reports of decreased kidney weight in offspring of
pregnant rats exposed to nicotine [28]. Similarly, it has been
reported that there is a positive association between kidney
malformation and maternal smoking [29]. Whilst the interaction
of carbon monoxide and nicotine in kidney organogenesis is not
clear, maternal smoking can cause disturbances in the interaction
between the ureteric bud and the metanephric mesenchyme.
Moreover, numerous immature renal corpuscles have been
observed in fetuses exposed to PEMCS, which is suggestive of
disturbed kidney development [22].
The placental volume data demonstrated that smaller placental
volumes are associated with PEMCS. Several studies have
documented a negative effect of PEMCS on placental structure,
particularly in the placentae of heavy smokers [21,30]. This
indicates that further in vivo studies of placental function in
PEMCS are required. There is also evidence of reduced volume
density of the fetal vessels in the terminal villi and reduced
exchange area in the placentae of women who smoke [31,32],
possibly leading to decreased uterine blood flow in the placenta
due to a vasoconstriction mechanism [33]. Further studies are in
progress and will involve relating placental diffusion in PEMCS to
placental weight and morphology.
Limitations of Our Study
MRI was used to study the effect of PEMCS on fetal organ
growth and fetal volume. Due to the challenges in recruiting this
particular, matched population, the study was small, reducing the
power for detecting subtle differences. Furthermore, this is an
observational study and, as such, it does not allow us to draw any
causal inferences about the reported associations between PEMCS
and organ growth. Fetal imaging is challenging for three reasons:
unpredictable fetal motion, variations in the position of the fetus
which means that the scan orientation must be adjusted for each
subject, and a large field of view (especially third trimester) which
can cause artifacts including wrap-around artifacts and signal
inhomogeneities. These potential limitations were generally
overcome by routinely oversampling the data and acquiring it in
orthogonal orientations. Measurements of each organ were made
on volume data sets acquired in at least two orientations (sagittal,
coronal or transverse), with the individual averaged measurements
for each organ varying by approximately 0–10%. These
measurements were made by a trained operator but the manual
segmentation approach used will inevitably have introduced some
additional systematic and random errors into the results. Two
different methods of drawing ROIs were used here. Computer-
assisted manual segmentation has shown comparable coefficients
of error of ,5% for brain volumetry [34] and up to 10% for
various fetal organs [35]. The second was the Cavalieri method for
which a coefficient of error has previously been reported to be less
than 5% for the fetal brain [13], and 10% for the fetal lung and
liver [12]. Fully automated ROI drawing would reduce some of
these errors further.
Conclusion
In conclusion, the results of the present study demonstrate that
intrauterine exposure to cigarette smoking is associated with
impaired fetal and fetal organ growth, particularly in the kidney
and brain.
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